Endothelin-A Receptor Antagonism Attenuates the Hypertension and Renal Injury in Dahl Salt-Sensitive Rats

Hypertension

Volumn 31, Issue 1, 1998, Pages 397-402

  Kassab, Salah ^a   Miller, M Todd ^a   Novak, Jacqueline ^a   Reckelhoff, Jane ^a   Clower, Ben ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRASENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR; POTASSIUM; PYRROLIDINE DERIVATIVE; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; HYALINE DEGENERATION; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; SODIUM INTAKE; ANIMAL; BLOOD; BLOOD FLOW; BLOOD PRESSURE; DRUG EFFECT; GENETICS; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; KIDNEY; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT STRAIN; SODIUM RESTRICTION; SYSTOLE; URINE; VASCULARIZATION;

ANIMALS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HYPERTENSION; KIDNEY; MALE; NATRIURESIS; POTASSIUM; PROTEINURIA; PYRROLIDINES; RATS; RATS, INBRED STRAINS; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; REGIONAL BLOOD FLOW; SODIUM; SODIUM, DIETARY; SYSTOLE;

EID: 0031606120     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.397     Document Type: Article

References (38)

1. Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis. 1997;29(1):2-26.
2. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. J Clin Invest. 1989;83:336-342.
3. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest. 1989;83:1762-1767.
4. Schiffrin E. L. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension. 1995;25:1135-1143.
5. Lariviere R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
6. Day R, Lariviere R, Schiffrin EL. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens. 1995;8:294-300.
7. Orisio S, Benigni A, Bruzzi I, Coma D, Perico N, Zoja C, Benatti L, Remuzzi G. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int. 1993;43:354-358.
8. Benigni A, Perico N, Gaspari F, Bellizzi L, Gabanelli M, Remuzzi G. Increased renal endothelin production in rats with reduced renal mass. Am J Physiol. 1991;260:F331-F339.
9. Li JS, Lariviere R, Schiffrin EL. Effect of a non selective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats: evidence of a role of endothelin in vascular hypertrophy. Hypertension. 1994;24:183-188.
10. Li JS, Schurch W, Schiffrin EL. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. Am J Hypertens. 1996;9:803-811.
11. Benigni A, Zoja C, Corna D, Orisio S, Longarretti L, Bertani T, Remuzzi G. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int. 1993;44:440-444.
12. Benigni A, Zoja C, Corna D, Orisio S, Facchinetti D, Benatti L, Remuzzi G. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Am J Kidney Dis. 1996;27(3):416-423.
13. Sterzel RB, Luft FC, Gao Y, Shnermann J, Briggs JP, Ganten D, Waldherr P, Schnabel E, Kriz W. Renal disease and the development of hypertension in salt-sensitive Dahl rats. Kidney Int. 1988;33:1119-1129.
14. Roman RJ. Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol. 1986;251:F57-F65.
15. Uehara Y, Numabe A, Hirawa N, Kawabata Y, Iwai J, Ono H, Matsuoka H, Takabatake Y, Yagi S, Sugimoto T. Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats. J Hypertens. 1991;9:719-728.
16. Uehara Y, Numabe A, Ishimitsu T, Matsuoka H, Yagi S, Sugimoto T. Radical scavengers of indapamide and renal protection in Dahl salt sensitive rats. Hypertens Res. 1992;15:17-26.
17. Goligorsky MS, Iijima K, Morgan M, Yanagisawa M, Masaki T, Lin L, Nasjletti A, Kaskel F, Frazer M, Badr KF. Role of endothelin in the development of Dahl hypertension. J Cardiovasc Pharmacol. 1991;17(Suppl.7):S484-S491.
18. Uehara Y, Takada S, Hirawa N, Kawabata Y, Ohshima N, Numabe A, Ishimitsu T, Goto A, Yagi S, Omata M. Vasoconstrictors and renal protection induced by B1-selective adrenoceptor antagonist Bisoprolol. J Cardiovasc Pharmacol. 1994;23:897-906.
19. Kassab S, Novak J, Miller T, Kirchner K, Granger JP. Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension. Hypertension. 1997;30:682-686.
20. A-selective receptor antagonist. J Pharmacol Exp Ther. 1996;276:473-481.
21. A receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat. J Am Soc Nephrol. 1997;8:1054-1060.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem. 1976;72:248-254.
23. Guyton AC. Kidneys and fluids in pressure regulation: small volume but large pressure changes. Hypertension. 1992;19:12-18.
24. Madeddu P, Troffa C, Glorioso N, Pazzola A, Soro A, Manunta P, Tonolo G, Demontis MP, Varoni MV, Anonia V. Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats. J Cardiovasc Pharmacol. 1989;14:818-825.
25. Hall JE, Granger JP, Hester RL, Montani JP. Mechanisms of sodium balance in hypertension: role of pressure natriuresis. J Hypertens. 4(Suppl. 4):S57-S65.
26. A). J Am Soc Nephrol. 1994;5:1074-1080.
27. Simonson MS, Herman WH. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. J Biol Chem. 1993;268:9347-9357.
28. Nakamura T, Ebihara I, Tomino Y, Koide H. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. Kidney Int. 1995;47:481-489.
29. A receptor activation. Am J Physiol. 1993;264:R222-R226.
30. Gellai M, DeWolf R, Pullen M, Nambi P. Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int. 1994;46:1287-1294.
31. B receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int. 1996;50:962-972.
32. Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H. Effect of a specific endothelin A receptor antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes. 1995;44:895-899.
33. Brooks DP, Contino LC, Storer B, Ohlstein EH. Increased endothelin excretion in rats with renal failure induced by partial nephrectomy. Br J Pharmacol. 1991;104:987-989.
34. Deray G, Carayon A, Maistre G, Benhmida M, Masson F, Barthelemy C, Petitclerc T, Jacobs C. Endothelin in chronic renal failure. Nephrol Dial Transplant. 1992;7:300-305.
35. Ohta K, Hirata Y, Shichiri M, Kanno K, Emori T, Tomita K, Marumo F. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int. 1991;39:307-311.
36. Egido J. Vasoactive hormones and renal sclerosis. Kidney Int. 1996;49:578-597.
37. Rupprecht HD, Schocklmann HO, Sterzel RB. Cell matrix interactions in the glomerular mesangium. Kidney Int. 1996;49:1575-1582.
38. Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H. Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med. 1993;122:149-155.